The debate over expanding Medicaid in Indiana so far has hinged on how much it will cost. But two recent studies suggest Hoosier employers should be focused on how much a Medicaid expansion will save them: perhaps as much as $400 million per year.
House Bill 1315, which is scheduled for a Senate floor hearing on Monday, would require pharmacists to check with a patient’s physician before automatically substituting a generic version of a biotech drug for a brand-name version.
Indiana lawmakers are advancing a bill that would make it illegal to possess or deal "lookalike" synthetic drugs similar to those known as "bath salts" and other nicknames.
The federal government has delayed action on Indiana's proposal to expand Medicaid because the state hasn't received public comment on the proposals, but the issue could be resolved quickly with two hearings set for next week, a spokeswoman for Gov. Mike Pence said Wednesday.
Purdue University said Tuesday that Indiana farmers received payouts for 2012 corn, soybean and wheat losses that are nearly twice as much as the previous record of $522 million in 2008.
Fishers-based Nexxt Spine LLC, a manufacturer of spinal implants, is consolidating operations and moving its headquarters and manufacturing facility to Noblesville.
More than two dozen of the world's largest pharmaceutical companies, including Indianapolis-based Eli Lilly and Co., have agreed to provide funding and other support to Interpol's battle against counterfeit prescription drugs.
Mike Sherman, the chief financial officer at West Lafayette-based Endocyte Inc., talked about how the drug firm’s funding partnership with New Jersey-based Merck & Co. Inc. has helped accelerate development of the company’s pipeline, which is branching out into drugs to treat cancers of the lung, prostate and breast.
A fellow conservative provided some support for Gov. Mike Pence’s claim that an expansion of Medicaid will become a “baby elephant” that eats up larger and larger shares of state resources.
One explanation for Indiana University Health’s decision to delay its Methodist Hospital expansion is that new “value-based” payment models appear to be pushing down hospitalization rates, according to a study released Friday.
Citing concerns about the economy and federal health reform, Indiana University Health has pressed pause on its plans to build a bed tower at Methodist Hospital that could have cost it as much as $500 million.
Eli Lilly and Co. and five other big drugmakers avoided paying $7 billion in U.S. taxes last year by shifting their profits overseas. The strategy has drawn the ire of some legislators.
Warsaw-based DePuy was accused of knowingly marketing a faulty implant that was later recalled.
Lawmakers are finding it difficult to write a law that effectively cracks down on the sale of synthetic drugs while remaining fair to businesses that might not know they’re on their shelves.
Local officials from around Indiana are making a push for the Legislature to require that people obtain a doctor's prescription to buy cold medications often used to make methamphetamine.
The proposal, which passed the Senate last month, is aimed at preventing the medicines from getting into the hands of people making methamphetamine.
While rural hospitals face sharp reductions in their operating incomes, most of the four major hospital systems based in Indianapolis will see only a marginal impact on their finances.
Trucking and auto fleet insurer Baldwin & Lyons Inc. plans to move its headquarters from downtown Indianapolis to Carmel by the end of the year and hopes to add 133 jobs over the next five years, the company announced Monday afternoon.
The Indiana Senate voted unanimously last week to require the Indiana Medicaid program to pay home health agencies, rural health clinics and federally qualified health centers for doing medical consultations, diagnoses and monitoring using videoconferencing, telephones or computers.
Eli Lilly and Co. has sued Roche Holding AG’s Genentech unit, asking a court to invalidate patents used to make treatments for cancer and autoimmune diseases.
